EUVIMEDEUVIMED entdecken
Crossref

Disseminated Varicella‐Zoster Virus Infection in Organ Transplant Recipients: A 10‐year Retrospective Study

Ryosuke Yamamuro, Alba Romero, Ahsha Khandelwal-Young, Atul Humar, Deepali Kumar

Transplant Infectious Disease · 2025-11 · 27 (6)

DOI: 10.1111/tid.70117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, online erschienen am 21.10.2025. Verfasst von Ryosuke Yamamuro und 4 weiteren Autor:innen. Beteiligte Einrichtung: Ajmera Transplant Centre, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Herpesvirus 3, Human, Organ Transplantation, Transplant Recipients, Herpes Zoster. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Data on disseminated herpes zoster (HZ) infections in solid organ transplant (SOT) recipients are limited. We aimed to investigate the clinical characteristics and outcomes of HZ infection in SOT patients presenting with microbiologically confirmed disease.

Methods

All SOT recipients who tested positive for varicella‐zoster virus (VZV) from any sample type between January 2013 and December 2022 were included. Disseminated HZ was defined as skin lesions involving > 2 contiguous dermatomes or evidence of end organ disease. An analysis of risk factors associated with disseminated infection was performed.

Results

A total of 146 adult SOT patients with confirmed VZV infections were included in the study. Of these, 4 were primary varicella and 142 were HZ. Median time to HZ presentation was 1.8 years (range 0.02–27). Disseminated HZ was diagnosed in 55/142(38.7%). Post‐herpetic neuralgia (PHN) occurred in 33(22.6%) patients and vaccine breakthrough in 5(3.5%). Hospitalization was in 101(71.6%) patients, and 5(3.5%) died within 30 days, none attributable to HZ. VZV DNAemia was detected in 12/13 (92.3%) patients with disseminated disease versus 11/29 (37.9%) with localized disease ( p = 0.002). Recurrent HZ rate was 10/142 (7.0%) over a median follow‐up of 4.1 years with 90% of recurrences occurring in thoracic transplant. On multivariable logistic regression, no clinical factors were associated with disseminated disease.

Conclusions

In a large cohort of SOT patients with VZV, disseminated disease and PHN were frequent. VZV DNAemia was noted in both disseminated and localized infections suggesting that subclinical detection of virus in blood is frequent. The implications of this require further study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 3, HumanOrgan TransplantationTransplant RecipientsHerpes ZosterVaricella Zoster Virus InfectionHumansMaleFemaleRetrospective StudiesMiddle AgedAdultAgedRisk FactorsNeuralgia, PostherpeticHospitalization

Stichwörter der Autor:innen

herpes zosterimmunocompromised hostpostherpetic neuralgiavaccination

Autor:innen und Institutionen

  • Ajmera Transplant Centre, Toronto, Ontario, Canada.
  • Hospital Germans Trias i Pujol, Barcelona, Spain.
  • University of St. Andrews, St. Andrews, UK.

Zitieren

APA

Yamamuro, R., Romero, A., Khandelwal-Young, A., Humar, A., & Kumar, D. (2025). Disseminated Varicella‐Zoster Virus Infection in Organ Transplant Recipients: A 10‐year Retrospective Study. Transplant Infectious Disease, 27(6). https://doi.org/10.1111/tid.70117

Vancouver

Yamamuro R, Romero A, Khandelwal-Young A, Humar A, Kumar D. Disseminated Varicella‐Zoster Virus Infection in Organ Transplant Recipients: A 10‐year Retrospective Study. Transplant Infectious Disease. 2025;27(6). doi:10.1111/tid.70117

BibTeX
@article{Yamamuro2025,
  author = {Yamamuro, Ryosuke and Romero, Alba and Khandelwal-Young, Ahsha and Humar, Atul and Kumar, Deepali},
  title = {Disseminated Varicella‐Zoster Virus Infection in Organ Transplant Recipients: A 10‐year Retrospective Study},
  journal = {Transplant Infectious Disease},
  year = {2025},
  volume = {27},
  number = {6},
  doi = {10.1111/tid.70117}
}
Kostenlos starten →